10-Q 1 hele-20230531.htm 10-Q hele-20230531
000091678902/282024Q1FALSE00009167892023-03-012023-05-310000916789dei:OtherAddressMember2023-03-012023-05-3100009167892023-06-29xbrli:shares00009167892023-05-31iso4217:USD00009167892023-02-28iso4217:USDxbrli:shares00009167892022-03-012022-05-310000916789us-gaap:CommonStockMember2022-02-280000916789us-gaap:AdditionalPaidInCapitalMember2022-02-280000916789us-gaap:AccumulatedOtherComprehensiveIncomeMember2022-02-280000916789us-gaap:RetainedEarningsMember2022-02-2800009167892022-02-280000916789us-gaap:RetainedEarningsMember2022-03-012022-05-310000916789us-gaap:AccumulatedOtherComprehensiveIncomeMember2022-03-012022-05-310000916789us-gaap:CommonStockMember2022-03-012022-05-310000916789us-gaap:AdditionalPaidInCapitalMember2022-03-012022-05-310000916789us-gaap:CommonStockMember2022-05-310000916789us-gaap:AdditionalPaidInCapitalMember2022-05-310000916789us-gaap:AccumulatedOtherComprehensiveIncomeMember2022-05-310000916789us-gaap:RetainedEarningsMember2022-05-3100009167892022-05-310000916789us-gaap:CommonStockMember2023-02-280000916789us-gaap:AdditionalPaidInCapitalMember2023-02-280000916789us-gaap:AccumulatedOtherComprehensiveIncomeMember2023-02-280000916789us-gaap:RetainedEarningsMember2023-02-280000916789us-gaap:RetainedEarningsMember2023-03-012023-05-310000916789us-gaap:AccumulatedOtherComprehensiveIncomeMember2023-03-012023-05-310000916789us-gaap:CommonStockMember2023-03-012023-05-310000916789us-gaap:AdditionalPaidInCapitalMember2023-03-012023-05-310000916789us-gaap:CommonStockMember2023-05-310000916789us-gaap:AdditionalPaidInCapitalMember2023-05-310000916789us-gaap:AccumulatedOtherComprehensiveIncomeMember2023-05-310000916789us-gaap:RetainedEarningsMember2023-05-31hele:segment0000916789hele:CurlsmithMember2022-04-222022-04-2200009167892021-06-072021-06-070000916789hele:LatinAmericaAndCaribbeanPersonalCareBusinessMember2022-03-252022-03-250000916789hele:CurlsmithMember2022-04-220000916789hele:CurlsmithMember2022-03-012022-05-310000916789us-gaap:TradeNamesMemberhele:CurlsmithMember2022-04-222022-04-220000916789us-gaap:CustomerRelationshipsMemberhele:CurlsmithMember2022-04-222022-04-220000916789hele:CurlsmithMember2022-03-012023-02-280000916789hele:CurlsmithMember2022-12-012023-02-280000916789hele:CurlsmithMember2023-03-012023-05-310000916789us-gaap:TradeNamesMemberhele:CurlsmithMember2022-04-220000916789us-gaap:CustomerRelationshipsMemberhele:CurlsmithMember2022-04-2200009167892022-04-220000916789us-gaap:RestrictedStockUnitsRSUMember2023-03-012023-05-310000916789us-gaap:RestrictedStockMember2023-03-012023-05-310000916789us-gaap:PerformanceSharesMember2023-03-012023-05-310000916789hele:MarketConditionSharesMember2023-03-012023-05-310000916789us-gaap:SellingGeneralAndAdministrativeExpensesMembersrt:DirectorMember2023-03-012023-05-310000916789us-gaap:SellingGeneralAndAdministrativeExpensesMembersrt:DirectorMember2022-03-012022-05-310000916789us-gaap:SellingGeneralAndAdministrativeExpensesMemberus-gaap:RestrictedStockUnitsRSUMember2023-03-012023-05-310000916789us-gaap:SellingGeneralAndAdministrativeExpensesMemberus-gaap:RestrictedStockUnitsRSUMember2022-03-012022-05-310000916789us-gaap:SellingGeneralAndAdministrativeExpensesMemberus-gaap:PerformanceSharesMember2023-03-012023-05-310000916789us-gaap:SellingGeneralAndAdministrativeExpensesMemberus-gaap:PerformanceSharesMember2022-03-012022-05-310000916789us-gaap:SellingGeneralAndAdministrativeExpensesMemberhele:MarketConditionSharesMember2023-03-012023-05-310000916789us-gaap:SellingGeneralAndAdministrativeExpensesMemberhele:MarketConditionSharesMember2022-03-012022-05-310000916789us-gaap:SellingGeneralAndAdministrativeExpensesMemberus-gaap:EmployeeStockMember2023-03-012023-05-310000916789us-gaap:SellingGeneralAndAdministrativeExpensesMemberus-gaap:EmployeeStockMember2022-03-012022-05-310000916789us-gaap:SellingGeneralAndAdministrativeExpensesMember2023-03-012023-05-310000916789us-gaap:SellingGeneralAndAdministrativeExpensesMember2022-03-012022-05-310000916789us-gaap:RestrictedStockMember2023-05-31xbrli:pure00009167892021-08-3100009167892021-08-252021-08-250000916789hele:OpenMarketAndTenderOfferMember2023-03-012023-05-310000916789hele:OpenMarketAndTenderOfferMember2022-03-012022-05-310000916789us-gaap:StockCompensationPlanMember2023-03-012023-05-310000916789us-gaap:StockCompensationPlanMember2022-03-012022-05-310000916789hele:ProjectPegasusMember2023-05-310000916789hele:ProjectPegasusMembersrt:MinimumMember2023-03-012023-05-310000916789hele:ProjectPegasusMembersrt:MaximumMember2023-03-012023-05-310000916789hele:ProjectPegasusMemberhele:RestructuringRecognitionOfSavingsPeriodOneMember2023-03-012023-05-310000916789hele:ProjectPegasusMemberhele:RestructuringRecognitionOfSavingsPeriodTwoMember2023-03-012023-05-310000916789hele:ProjectPegasusMemberhele:RestructuringRecognitionOfSavingsPeriodThreeMember2023-03-012023-05-310000916789hele:ProjectPegasusMember2023-03-012023-05-310000916789hele:ProjectPegasusMembersrt:MinimumMember2023-05-310000916789hele:ProjectPegasusMembersrt:MaximumMember2023-05-310000916789hele:ProjectPegasusMemberhele:HomeOutdoorMember2023-03-012023-05-310000916789hele:ProjectPegasusMemberhele:BeautyWellnessMember2023-03-012023-05-310000916789hele:ProjectPegasusMember2022-06-012023-05-310000916789us-gaap:EmployeeSeveranceMemberhele:ProjectPegasusMember2023-02-280000916789us-gaap:EmployeeSeveranceMemberhele:ProjectPegasusMember2023-03-012023-05-310000916789us-gaap:EmployeeSeveranceMemberhele:ProjectPegasusMember2023-05-310000916789hele:ProjectPegasusMemberhele:ProfessionalFeesMember2023-02-280000916789hele:ProjectPegasusMemberhele:ProfessionalFeesMember2023-03-012023-05-310000916789hele:ProjectPegasusMemberhele:ProfessionalFeesMember2023-05-310000916789hele:ProjectPegasusMemberus-gaap:ContractTerminationMember2023-02-280000916789hele:ProjectPegasusMemberus-gaap:ContractTerminationMember2023-03-012023-05-310000916789hele:ProjectPegasusMemberus-gaap:ContractTerminationMember2023-05-310000916789us-gaap:OtherRestructuringMemberhele:ProjectPegasusMember2023-02-280000916789us-gaap:OtherRestructuringMemberhele:ProjectPegasusMember2023-03-012023-05-310000916789us-gaap:OtherRestructuringMemberhele:ProjectPegasusMember2023-05-310000916789hele:ProjectPegasusMember2023-02-2800009167892021-12-23hele:renewal0000916789hele:HealthWellnessMemberus-gaap:CostOfSalesMember2023-03-012023-05-310000916789hele:HealthWellnessMemberus-gaap:CostOfSalesMember2022-03-012022-05-310000916789hele:HealthWellnessMemberus-gaap:SellingGeneralAndAdministrativeExpensesMember2023-03-012023-05-310000916789hele:HealthWellnessMemberus-gaap:SellingGeneralAndAdministrativeExpensesMember2022-03-012022-05-310000916789hele:HealthWellnessMember2023-03-012023-05-310000916789hele:HealthWellnessMember2022-03-012022-05-310000916789hele:HealthWellnessMemberhele:ObsoletePackagingMemberus-gaap:CostOfSalesMember2023-03-012023-05-310000916789hele:WeatherRelatedIncidentMember2022-03-012022-05-3100009167892022-12-012023-02-280000916789us-gaap:RevolvingCreditFacilityMemberus-gaap:LineOfCreditMemberhele:CreditAgreementWithBankOfAmericaMember2023-05-310000916789us-gaap:RevolvingCreditFacilityMemberus-gaap:LineOfCreditMemberhele:CreditAgreementWithBankOfAmericaMember2023-02-280000916789us-gaap:SecuredDebtMemberus-gaap:LineOfCreditMemberhele:CreditAgreementWithBankOfAmericaMember2023-05-310000916789us-gaap:SecuredDebtMemberus-gaap:LineOfCreditMemberhele:CreditAgreementWithBankOfAmericaMember2023-02-280000916789us-gaap:LineOfCreditMemberhele:CreditAgreementWithBankOfAmericaMember2023-05-310000916789us-gaap:LineOfCreditMemberhele:CreditAgreementWithBankOfAmericaMember2023-02-280000916789us-gaap:LineOfCreditMember2023-05-310000916789us-gaap:LineOfCreditMember2023-02-280000916789us-gaap:RevolvingCreditFacilityMember2023-05-310000916789us-gaap:RevolvingCreditFacilityMemberus-gaap:LineOfCreditMemberhele:CreditAgreementWithBankOfAmericaMember2022-03-012023-02-280000916789us-gaap:RevolvingCreditFacilityMemberus-gaap:LineOfCreditMemberhele:CreditAgreementWithBankOfAmericaMember2022-06-280000916789srt:MinimumMemberus-gaap:LineOfCreditMemberus-gaap:BaseRateMember2022-02-282022-02-280000916789us-gaap:LineOfCreditMembersrt:MaximumMemberus-gaap:BaseRateMember2022-02-282022-02-280000916789srt:MinimumMemberus-gaap:LineOfCreditMemberus-gaap:SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMember2022-02-282022-02-280000916789us-gaap:LineOfCreditMembersrt:MaximumMemberus-gaap:SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMember2022-02-282022-02-280000916789us-gaap:LineOfCreditMemberhele:CreditAgreementWithBankOfAmericaMemberus-gaap:SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMember2022-02-282022-02-280000916789us-gaap:LetterOfCreditMemberus-gaap:LineOfCreditMember2023-05-310000916789us-gaap:FairValueMeasurementsRecurringMemberus-gaap:FairValueInputsLevel2Memberus-gaap:MoneyMarketFundsMemberus-gaap:EstimateOfFairValueFairValueDisclosureMember2023-05-310000916789us-gaap:FairValueMeasurementsRecurringMemberus-gaap:FairValueInputsLevel2Memberus-gaap:MoneyMarketFundsMemberus-gaap:EstimateOfFairValueFairValueDisclosureMember2023-02-280000916789us-gaap:FairValueMeasurementsRecurringMemberus-gaap:FairValueInputsLevel2Memberus-gaap:InterestRateSwaptionMemberus-gaap:EstimateOfFairValueFairValueDisclosureMember2023-05-310000916789us-gaap:FairValueMeasurementsRecurringMemberus-gaap:FairValueInputsLevel2Memberus-gaap:InterestRateSwaptionMemberus-gaap:EstimateOfFairValueFairValueDisclosureMember2023-02-280000916789us-gaap:FairValueMeasurementsRecurringMemberus-gaap:FairValueInputsLevel2Memberus-gaap:EstimateOfFairValueFairValueDisclosureMemberus-gaap:ForeignExchangeContractMember2023-05-310000916789us-gaap:FairValueMeasurementsRecurringMemberus-gaap:FairValueInputsLevel2Memberus-gaap:EstimateOfFairValueFairValueDisclosureMemberus-gaap:ForeignExchangeContractMember2023-02-280000916789us-gaap:FairValueMeasurementsRecurringMemberus-gaap:FairValueInputsLevel2Memberus-gaap:EstimateOfFairValueFairValueDisclosureMember2023-05-310000916789us-gaap:FairValueMeasurementsRecurringMemberus-gaap:FairValueInputsLevel2Memberus-gaap:EstimateOfFairValueFairValueDisclosureMember2023-02-280000916789us-gaap:SalesRevenueNetMemberhele:SegmentGeographicalGroupsOfCountriesNonUSDTransactionsMemberus-gaap:GeographicConcentrationRiskMember2023-03-012023-05-310000916789us-gaap:SalesRevenueNetMemberhele:SegmentGeographicalGroupsOfCountriesNonUSDTransactionsMemberus-gaap:GeographicConcentrationRiskMember2022-03-012022-05-310000916789currency:EURus-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:ShortMemberus-gaap:ForeignExchangeContractMember2023-05-31iso4217:EUR0000916789currency:EURus-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:ShortMemberus-gaap:PrepaidExpensesAndOtherCurrentAssetsMemberus-gaap:ForeignExchangeContractMember2023-05-310000916789currency:EURus-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:ShortMemberus-gaap:OtherNoncurrentAssetsMemberus-gaap:ForeignExchangeContractMember2023-05-310000916789currency:EURus-gaap:AccountsPayableAndAccruedLiabilitiesMemberus-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:ShortMemberus-gaap:ForeignExchangeContractMember2023-05-310000916789currency:EURus-gaap:OtherNoncurrentLiabilitiesMemberus-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:ShortMemberus-gaap:ForeignExchangeContractMember2023-05-310000916789currency:CADus-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:ShortMemberus-gaap:ForeignExchangeContractMember2023-05-31iso4217:CAD0000916789currency:CADus-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:ShortMemberus-gaap:PrepaidExpensesAndOtherCurrentAssetsMemberus-gaap:ForeignExchangeContractMember2023-05-310000916789currency:CADus-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:ShortMemberus-gaap:OtherNoncurrentAssetsMemberus-gaap:ForeignExchangeContractMember2023-05-310000916789currency:CADus-gaap:AccountsPayableAndAccruedLiabilitiesMemberus-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:ShortMemberus-gaap:ForeignExchangeContractMember2023-05-310000916789currency:CADus-gaap:OtherNoncurrentLiabilitiesMemberus-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:ShortMemberus-gaap:ForeignExchangeContractMember2023-05-310000916789us-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:ShortMembercurrency:GBPus-gaap:ForeignExchangeContractMember2023-05-31iso4217:GBP0000916789us-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:ShortMembercurrency:GBPus-gaap:PrepaidExpensesAndOtherCurrentAssetsMemberus-gaap:ForeignExchangeContractMember2023-05-310000916789us-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:ShortMembercurrency:GBPus-gaap:OtherNoncurrentAssetsMemberus-gaap:ForeignExchangeContractMember2023-05-310000916789us-gaap:AccountsPayableAndAccruedLiabilitiesMemberus-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:ShortMembercurrency:GBPus-gaap:ForeignExchangeContractMember2023-05-310000916789us-gaap:OtherNoncurrentLiabilitiesMemberus-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:ShortMembercurrency:GBPus-gaap:ForeignExchangeContractMember2023-05-310000916789us-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:ShortMembercurrency:NOKus-gaap:ForeignExchangeContractMember2023-05-31iso4217:NOK0000916789us-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:ShortMembercurrency:NOKus-gaap:PrepaidExpensesAndOtherCurrentAssetsMemberus-gaap:ForeignExchangeContractMember2023-05-310000916789us-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:ShortMembercurrency:NOKus-gaap:OtherNoncurrentAssetsMemberus-gaap:ForeignExchangeContractMember2023-05-310000916789us-gaap:AccountsPayableAndAccruedLiabilitiesMemberus-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:ShortMembercurrency:NOKus-gaap:ForeignExchangeContractMember2023-05-310000916789us-gaap:OtherNoncurrentLiabilitiesMemberus-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:ShortMembercurrency:NOKus-gaap:ForeignExchangeContractMember2023-05-310000916789us-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:InterestRateSwapMember2023-05-310000916789us-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:InterestRateSwapMemberus-gaap:PrepaidExpensesAndOtherCurrentAssetsMember2023-05-310000916789us-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:InterestRateSwapMemberus-gaap:OtherNoncurrentAssetsMember2023-05-310000916789us-gaap:AccountsPayableAndAccruedLiabilitiesMemberus-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:InterestRateSwapMember2023-05-310000916789us-gaap:OtherNoncurrentLiabilitiesMemberus-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:InterestRateSwapMember2023-05-310000916789us-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:PrepaidExpensesAndOtherCurrentAssetsMember2023-05-310000916789us-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:OtherNoncurrentAssetsMember2023-05-310000916789us-gaap:AccountsPayableAndAccruedLiabilitiesMemberus-gaap:DesignatedAsHedgingInstrumentMember2023-05-310000916789us-gaap:OtherNoncurrentLiabilitiesMemberus-gaap:DesignatedAsHedgingInstrumentMember2023-05-310000916789us-gaap:CrossCurrencyInterestRateContractMembercurrency:EURus-gaap:NondesignatedMember2023-05-310000916789us-gaap:CrossCurrencyInterestRateContractMembercurrency:EURus-gaap:NondesignatedMemberus-gaap:PrepaidExpensesAndOtherCurrentAssetsMember2023-05-310000916789us-gaap:CrossCurrencyInterestRateContractMembercurrency:EURus-gaap:NondesignatedMemberus-gaap:OtherNoncurrentAssetsMember2023-05-310000916789us-gaap:CrossCurrencyInterestRateContractMembercurrency:EURus-gaap:AccountsPayableAndAccruedLiabilitiesMemberus-gaap:NondesignatedMember2023-05-310000916789us-gaap:CrossCurrencyInterestRateContractMembercurrency:EURus-gaap:OtherNoncurrentLiabilitiesMemberus-gaap:NondesignatedMember2023-05-310000916789us-gaap:NondesignatedMemberus-gaap:PrepaidExpensesAndOtherCurrentAssetsMember2023-05-310000916789us-gaap:NondesignatedMemberus-gaap:OtherNoncurrentAssetsMember2023-05-310000916789us-gaap:AccountsPayableAndAccruedLiabilitiesMemberus-gaap:NondesignatedMember2023-05-310000916789us-gaap:OtherNoncurrentLiabilitiesMemberus-gaap:NondesignatedMember2023-05-310000916789us-gaap:PrepaidExpensesAndOtherCurrentAssetsMember2023-05-310000916789us-gaap:OtherNoncurrentAssetsMember2023-05-310000916789us-gaap:AccountsPayableAndAccruedLiabilitiesMember2023-05-310000916789us-gaap:OtherNoncurrentLiabilitiesMember2023-05-310000916789currency:EURus-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:ShortMemberus-gaap:ForeignExchangeContractMember2023-02-280000916789currency:EURus-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:ShortMemberus-gaap:PrepaidExpensesAndOtherCurrentAssetsMemberus-gaap:ForeignExchangeContractMember2023-02-280000916789currency:EURus-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:ShortMemberus-gaap:OtherNoncurrentAssetsMemberus-gaap:ForeignExchangeContractMember2023-02-280000916789currency:EURus-gaap:AccountsPayableAndAccruedLiabilitiesMemberus-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:ShortMemberus-gaap:ForeignExchangeContractMember2023-02-280000916789currency:EURus-gaap:OtherNoncurrentLiabilitiesMemberus-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:ShortMemberus-gaap:ForeignExchangeContractMember2023-02-280000916789currency:CADus-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:ShortMemberus-gaap:ForeignExchangeContractMember2023-02-280000916789currency:CADus-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:ShortMemberus-gaap:PrepaidExpensesAndOtherCurrentAssetsMemberus-gaap:ForeignExchangeContractMember2023-02-280000916789currency:CADus-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:ShortMemberus-gaap:OtherNoncurrentAssetsMemberus-gaap:ForeignExchangeContractMember2023-02-280000916789currency:CADus-gaap:AccountsPayableAndAccruedLiabilitiesMemberus-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:ShortMemberus-gaap:ForeignExchangeContractMember2023-02-280000916789currency:CADus-gaap:OtherNoncurrentLiabilitiesMemberus-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:ShortMemberus-gaap:ForeignExchangeContractMember2023-02-280000916789us-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:ShortMembercurrency:GBPus-gaap:ForeignExchangeContractMember2023-02-280000916789us-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:ShortMembercurrency:GBPus-gaap:PrepaidExpensesAndOtherCurrentAssetsMemberus-gaap:ForeignExchangeContractMember2023-02-280000916789us-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:ShortMembercurrency:GBPus-gaap:OtherNoncurrentAssetsMemberus-gaap:ForeignExchangeContractMember2023-02-280000916789us-gaap:AccountsPayableAndAccruedLiabilitiesMemberus-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:ShortMembercurrency:GBPus-gaap:ForeignExchangeContractMember2023-02-280000916789us-gaap:OtherNoncurrentLiabilitiesMemberus-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:ShortMembercurrency:GBPus-gaap:ForeignExchangeContractMember2023-02-280000916789us-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:ShortMembercurrency:NOKus-gaap:ForeignExchangeContractMember2023-02-280000916789us-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:ShortMembercurrency:NOKus-gaap:PrepaidExpensesAndOtherCurrentAssetsMemberus-gaap:ForeignExchangeContractMember2023-02-280000916789us-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:ShortMembercurrency:NOKus-gaap:OtherNoncurrentAssetsMemberus-gaap:ForeignExchangeContractMember2023-02-280000916789us-gaap:AccountsPayableAndAccruedLiabilitiesMemberus-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:ShortMembercurrency:NOKus-gaap:ForeignExchangeContractMember2023-02-280000916789us-gaap:OtherNoncurrentLiabilitiesMemberus-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:ShortMembercurrency:NOKus-gaap:ForeignExchangeContractMember2023-02-280000916789us-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:InterestRateSwapMember2023-02-280000916789us-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:InterestRateSwapMemberus-gaap:PrepaidExpensesAndOtherCurrentAssetsMember2023-02-280000916789us-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:InterestRateSwapMemberus-gaap:OtherNoncurrentAssetsMember2023-02-280000916789us-gaap:AccountsPayableAndAccruedLiabilitiesMemberus-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:InterestRateSwapMember2023-02-280000916789us-gaap:OtherNoncurrentLiabilitiesMemberus-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:InterestRateSwapMember2023-02-280000916789us-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:PrepaidExpensesAndOtherCurrentAssetsMember2023-02-280000916789us-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:OtherNoncurrentAssetsMember2023-02-280000916789us-gaap:AccountsPayableAndAccruedLiabilitiesMemberus-gaap:DesignatedAsHedgingInstrumentMember2023-02-280000916789us-gaap:OtherNoncurrentLiabilitiesMemberus-gaap:DesignatedAsHedgingInstrumentMember2023-02-280000916789us-gaap:CrossCurrencyInterestRateContractMembercurrency:EURus-gaap:NondesignatedMember2023-02-280000916789currency:EURus-gaap:NondesignatedMemberus-gaap:PrepaidExpensesAndOtherCurrentAssetsMemberus-gaap:ForeignExchangeContractMember2023-02-280000916789currency:EURus-gaap:NondesignatedMemberus-gaap:OtherNoncurrentAssetsMemberus-gaap:ForeignExchangeContractMember2023-02-280000916789currency:EURus-gaap:AccountsPayableAndAccruedLiabilitiesMemberus-gaap:NondesignatedMemberus-gaap:ForeignExchangeContractMember2023-02-280000916789currency:EURus-gaap:OtherNoncurrentLiabilitiesMemberus-gaap:NondesignatedMemberus-gaap:ForeignExchangeContractMember2023-02-280000916789us-gaap:CrossCurrencyInterestRateContractMemberus-gaap:NondesignatedMembercurrency:GBP2023-02-280000916789us-gaap:NondesignatedMembercurrency:GBPus-gaap:PrepaidExpensesAndOtherCurrentAssetsMemberus-gaap:ForeignExchangeContractMember2023-02-280000916789us-gaap:NondesignatedMembercurrency:GBPus-gaap:OtherNoncurrentAssetsMemberus-gaap:ForeignExchangeContractMember2023-02-280000916789us-gaap:AccountsPayableAndAccruedLiabilitiesMemberus-gaap:NondesignatedMembercurrency:GBPus-gaap:ForeignExchangeContractMember2023-02-280000916789us-gaap:OtherNoncurrentLiabilitiesMemberus-gaap:NondesignatedMembercurrency:GBPus-gaap:ForeignExchangeContractMember2023-02-280000916789us-gaap:NondesignatedMemberus-gaap:PrepaidExpensesAndOtherCurrentAssetsMember2023-02-280000916789us-gaap:NondesignatedMemberus-gaap:OtherNoncurrentAssetsMember2023-02-280000916789us-gaap:AccountsPayableAndAccruedLiabilitiesMemberus-gaap:NondesignatedMember2023-02-280000916789us-gaap:OtherNoncurrentLiabilitiesMemberus-gaap:NondesignatedMember2023-02-280000916789us-gaap:PrepaidExpensesAndOtherCurrentAssetsMember2023-02-280000916789us-gaap:OtherNoncurrentAssetsMember2023-02-280000916789us-gaap:AccountsPayableAndAccruedLiabilitiesMember2023-02-280000916789us-gaap:OtherNoncurrentLiabilitiesMember2023-02-280000916789us-gaap:CashFlowHedgingMemberus-gaap:ForeignExchangeContractMember2023-03-012023-05-310000916789us-gaap:CashFlowHedgingMemberus-gaap:ForeignExchangeContractMember2022-03-012022-05-310000916789us-gaap:SellingGeneralAndAdministrativeExpensesMemberus-gaap:CashFlowHedgingMemberus-gaap:ForeignExchangeContractMember2023-03-012023-05-310000916789us-gaap:SellingGeneralAndAdministrativeExpensesMemberus-gaap:CashFlowHedgingMemberus-gaap:ForeignExchangeContractMember2022-03-012022-05-310000916789us-gaap:InterestRateSwapMemberus-gaap:CashFlowHedgingMember2023-03-012023-05-310000916789us-gaap:InterestRateSwapMemberus-gaap:CashFlowHedgingMember2022-03-012022-05-310000916789us-gaap:InterestRateSwapMemberus-gaap:CashFlowHedgingMemberus-gaap:InterestExpenseMember2023-03-012023-05-310000916789us-gaap:InterestRateSwapMemberus-gaap:CashFlowHedgingMemberus-gaap:InterestExpenseMember2022-03-012022-05-310000916789us-gaap:SellingGeneralAndAdministrativeExpensesMemberus-gaap:ForwardContractsMember2023-03-012023-05-310000916789us-gaap:SellingGeneralAndAdministrativeExpensesMemberus-gaap:ForwardContractsMember2022-03-012022-05-310000916789us-gaap:CrossCurrencyInterestRateContractMemberus-gaap:SellingGeneralAndAdministrativeExpensesMember2023-03-012023-05-310000916789us-gaap:CrossCurrencyInterestRateContractMemberus-gaap:SellingGeneralAndAdministrativeExpensesMember2022-03-012022-05-310000916789us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember2022-02-280000916789us-gaap:AccumulatedTranslationAdjustmentMember2022-02-280000916789us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember2022-03-012022-05-310000916789us-gaap:AccumulatedTranslationAdjustmentMember2022-03-012022-05-310000916789us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember2022-05-310000916789us-gaap:AccumulatedTranslationAdjustmentMember2022-05-310000916789us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember2023-02-280000916789us-gaap:AccumulatedTranslationAdjustmentMember2023-02-280000916789us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember2023-03-012023-05-310000916789us-gaap:AccumulatedTranslationAdjustmentMember2023-03-012023-05-310000916789us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember2023-05-310000916789us-gaap:AccumulatedTranslationAdjustmentMember2023-05-310000916789hele:HousewaresSegmentMember2023-03-012023-05-310000916789hele:BeautyWellnessMember2023-03-012023-05-310000916789hele:HousewaresSegmentMember2022-03-012022-05-310000916789hele:BeautyWellnessMember2022-03-012022-05-310000916789country:US2023-03-012023-05-310000916789us-gaap:RevenueFromContractWithCustomerMembercountry:USus-gaap:GeographicConcentrationRiskMember2023-03-012023-05-310000916789country:US2022-03-012022-05-310000916789us-gaap:RevenueFromContractWithCustomerMembercountry:USus-gaap:GeographicConcentrationRiskMember2022-03-012022-05-310000916789us-gaap:NonUsMember2023-03-012023-05-310000916789us-gaap:RevenueFromContractWithCustomerMemberus-gaap:NonUsMemberus-gaap:GeographicConcentrationRiskMember2023-03-012023-05-310000916789us-gaap:NonUsMember2022-03-012022-05-310000916789us-gaap:RevenueFromContractWithCustomerMemberus-gaap:NonUsMemberus-gaap:GeographicConcentrationRiskMember2022-03-012022-05-310000916789us-gaap:RevenueFromContractWithCustomerMemberus-gaap:GeographicConcentrationRiskMember2023-03-012023-05-310000916789us-gaap:RevenueFromContractWithCustomerMemberus-gaap:GeographicConcentrationRiskMember2022-03-012022-05-310000916789us-gaap:EmployeeStockOptionMember2023-03-012023-05-310000916789us-gaap:EmployeeStockOptionMember2022-03-012022-05-31
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 10-Q
(Mark One)
☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
For the quarterly period ended May 31, 2023
or
☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
For the transition period from __ to __
Commission File Number: 001-14669
helenoftroylogoa15.jpg
HELEN OF TROY LIMITED
(Exact name of registrant as specified in its charter)
Bermuda 74-2692550
(State or other jurisdiction (I.R.S. Employer
of incorporation or organization) Identification No.)
Clarendon House
2 Church Street
Hamilton, Bermuda
(Address of principal executive offices)
1 Helen of Troy Plaza
El Paso, Texas 79912
(Registrant's United States Mailing Address) (Zip Code)
(915) 225-8000
(Registrant’s telephone number, including area code)

Securities registered pursuant to Section 12(b) of the Act: 
Title of each class Trading Symbol(s) Name of each exchange on which registered
Common Shares, $0.10 par value per share HELE The NASDAQ Stock Market LLC
Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.  Yes ☒ No ☐
Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).       Yes ☒ No ☐
Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act.
Large accelerated filer
☒Accelerated filer☐
Non-accelerated filer
☐
Smaller reporting company
☐
Emerging growth company
☐
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes ☐ No ☒
Indicate the number of shares outstanding of each of the issuer’s classes of common stock, as of the latest practicable date.
As of June 29, 2023, there were 24,099,376 common shares, $0.10 par value per share, outstanding.

HELEN OF TROY LIMITED AND SUBSIDIARIES
FORM 10-Q
TABLE OF CONTENTS
  PAGE 
   
 
  
  
 
 
 
 
 
 
 
 
 
 
 
 
   
   
   
   
 
   
   
   
   
   
1
PART I.   FINANCIAL INFORMATION

ITEM 1.   FINANCIAL STATEMENTS

HELEN OF TROY LIMITED AND SUBSIDIARIES
Condensed Consolidated Balance Sheets (Unaudited)
(in thousands, except shares and par value)May 31, 2023February 28, 2023
Assets  
Assets, current:  
Cash and cash equivalents$38,869 $29,073 
Receivables - principally trade, less allowances of $4,959 and $1,678
349,699 377,604 
Inventory433,913 455,485 
Prepaid expenses and other current assets24,458 24,721 
Income taxes receivable9,118 5,158 
Total assets, current856,057 892,041 
Property and equipment, net of accumulated depreciation of $184,972 and $178,961
354,195 351,793 
Goodwill1,066,730 1,066,479 
Other intangible assets, net of accumulated amortization of $173,232 and $168,574
549,375 553,883 
Operating lease assets37,362 38,751 
Deferred tax assets, net2,757 2,781 
Other assets6,352 7,987 
Total assets$2,872,828 $2,913,715 
Liabilities and Stockholders' Equity  
Liabilities, current:  
Accounts payable, principally trade$226,191 $190,598 
Accrued expenses and other current liabilities193,049 200,718 
Income taxes payable15,316 14,778 
Long-term debt, current maturities6,235 6,064 
Total liabilities, current440,791 412,158 
Long-term debt, excluding current maturities830,922 928,348 
Lease liabilities, non-current41,322 42,672 
Deferred tax liabilities, net30,789 28,048 
Other liabilities, non-current14,096 13,678 
Total liabilities1,357,920 1,424,904 
Commitments and contingencies
Stockholders' equity:  
Cumulative preferred stock, non-voting, $1.00 par. Authorized 2,000,000 shares; none issued
— — 
Common stock, $0.10 par. Authorized 50,000,000 shares; 24,096,946 and 23,994,405 shares issued and outstanding
2,410 2,399 
Additional paid in capital 324,497 317,277 
Accumulated other comprehensive income
1,232 4,947 
Retained earnings1,186,769 1,164,188 
Total stockholders' equity1,514,908 1,488,811 
Total liabilities and stockholders' equity$2,872,828 $2,913,715 

See accompanying notes to condensed consolidated financial statements.
2
HELEN OF TROY LIMITED AND SUBSIDIARIES
Condensed Consolidated Statements of Income (Unaudited) 

 Three Months Ended May 31,
(in thousands, except per share data)20232022
Sales revenue, net$474,672 $508,078 
Cost of goods sold259,041 296,907 
Gross profit215,631 211,171 
Selling, general and administrative expense (“SG&A”)
167,635 177,230 
Restructuring charges7,355 2 
Operating income40,641 33,939 
Non-operating income, net137 67 
Interest expense14,052 4,373 
Income before income tax26,726 29,633 
Income tax expense4,145 5,038 
Net income$22,581 $24,595 
Earnings per share (“EPS”):
  
Basic$0.94 $1.03 
Diluted 0.94 1.02 
Weighted average shares used in computing EPS:  
Basic24,049 23,865 
Diluted24,134 24,122 

See accompanying notes to condensed consolidated financial statements.
3
HELEN OF TROY LIMITED AND SUBSIDIARIES
Condensed Consolidated Statements of Comprehensive Income (Unaudited) 

 Three Months Ended May 31,
(in thousands)20232022
Net income$22,581 $24,595 
Other comprehensive (loss) income, net of tax:
Cash flow hedge activity - interest rate swaps(3,092)2,206 
Cash flow hedge activity - foreign currency contracts(623)953 
Total other comprehensive (loss) income, net of tax(3,715)3,159 
Comprehensive income$18,866 $27,754 

See accompanying notes to condensed consolidated financial statements.
4
HELEN OF TROY LIMITED AND SUBSIDIARIES
Condensed Consolidated Statements of Stockholders’ Equity (Unaudited)

Common StockAdditional Paid in CapitalAccumulated Other Comprehensive IncomeRetained EarningsTotal Stockholders' Equity
(in thousands, including shares) SharesPar
Value
Balances at February 28, 202223,800 $2,380 $303,740 $202 $1,021,017 $1,327,339 
Net income— — — — 24,595 24,595 
Other comprehensive income, net of tax— — — 3,159 — 3,159 
Exercise of stock options8 1 658 — — 659 
Issuance and settlement of restricted stock235 24 (24)— — — 
Issuance of common stock related to stock purchase plan13 1 2,274 — — 2,275 
Common stock repurchased and retired(89)(9)(18,113)— (102)(18,224)
Share-based compensation— — 16,619 — — 16,619 
Balances at May 31, 202223,967 $2,397 $305,154 $3,361 $1,045,510 $1,356,422 

Balances at February 28, 202323,994 $2,399 $317,277 $4,947 $1,164,188 $1,488,811 
Net income— — — — 22,581 22,581 
Other comprehensive loss, net of tax— — — (3,715)— (3,715)
Exercise of stock options5 1 211 — — 212 
Issuance and settlement of restricted stock120 12 (12)— — — 
Issuance of common stock related to stock purchase plan23 2 2,166 — — 2,168 
Common stock repurchased and retired(45)(4)(4,442)— — (4,446)
Share-based compensation— — 9,297 — — 9,297 
Balances at May 31, 202324,097 $2,410 $324,497 $1,232 $1,186,769 $1,514,908 

See accompanying notes to condensed consolidated financial statements.



5
HELEN OF TROY LIMITED AND SUBSIDIARIES
Condensed Consolidated Statements of Cash Flows (Unaudited)
 Three Months Ended May 31,
(in thousands)20232022
Cash provided (used) by operating activities:  
Net income$22,581 $24,595 
Adjustments to reconcile net income to net cash provided (used) by operating activities:  
Depreciation and amortization10,715 10,498 
Amortization of financing costs308 253 
Non-cash operating lease expense2,338 2,543 
Provision for credit losses 3,389 320 
Non-cash share-based compensation9,297 16,619 
Gain on sale of Personal Care business— (1,336)
Gain on the sale or disposal of property and equipment(246)— 
Deferred income taxes and tax credits3,897 614 
Changes in operating capital, net of effects of acquisitions of businesses:  
Receivables26,733 (14,639)
Inventory21,572 (47,781)
Prepaid expenses and other current assets(1,420)651 
Other assets and liabilities, net(656)(823)
Accounts payable36,644 10,027 
Accrued expenses and other current liabilities(10,734)(28,764)
Accrued income taxes(3,362)(11,205)
Net cash provided (used) by operating activities
121,056 (38,428)
Cash used by investing activities:  
Capital and intangible asset expenditures(11,877)(76,202)
Net payments to acquire businesses, net of cash acquired— (148,111)
Proceeds from sale of Personal Care business— 1,804 
Proceeds from the sale of property and equipment246 — 
Net cash used by investing activities
(11,631)(222,509)
Cash (used) provided by financing activities:  
Proceeds from revolving loans70,150 447,000 
Repayment of revolving loans(166,150)(153,000)
Repayment of long-term debt
(1,563)(1,900)
Proceeds from share issuances under share-based compensation plans2,380 2,934 
Payments for repurchases of common stock(4,446)(18,224)
Net cash (used) provided by financing activities(99,629)276,810 
Net increase in cash and cash equivalents
9,796 15,873 
Cash and cash equivalents, beginning balance29,073 33,381 
Cash and cash equivalents, ending balance$38,869 $49,254 
Supplemental non-cash investing activity:
Capital expenditures included in accounts payable$2,579 $12,812 

See accompanying notes to condensed consolidated financial statements.
6
HELEN OF TROY LIMITED AND SUBSIDIARIES
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (Unaudited)
May 31, 2023

Note 1 - Basis of Presentation and Related Information

Corporate Overview

The accompanying condensed consolidated financial statements contain all adjustments (consisting of normal recurring adjustments) necessary to present fairly our consolidated financial position as of May 31, 2023 and February 28, 2023, and the results of our consolidated operations for the interim periods presented. We follow the same accounting policies when preparing quarterly financial data as we use for preparing annual data. These statements should be read in conjunction with the consolidated financial statements and the notes included in our latest annual report on Form 10-K for the fiscal year ended February 28, 2023 (“Form 10-K”), and our other reports on file with the Securities and Exchange Commission (the “SEC”).

When used in these notes, unless otherwise indicated or the context suggests otherwise, references to “the Company”, “our Company”, “Helen of Troy”, “we”, “us”, or “our” refer to Helen of Troy Limited and its subsidiaries, which are all wholly-owned. We refer to our common shares, par value $0.10 per share, as “common stock.” References to “the FASB” refer to the Financial Accounting Standards Board. References to “GAAP” refer to accounting principles generally accepted in the United States of America (the “U.S.”). References to “ASU” refer to the codification of GAAP in the Accounting Standards Updates issued by the FASB. References to “ASC” refer to the codification of GAAP in the Accounting Standards Codification issued by the FASB.

We incorporated as Helen of Troy Corporation in Texas in 1968 and were reorganized as Helen of Troy Limited in Bermuda in 1994. We are a leading consumer products company offering creative products and solutions for our customers through a diversified portfolio of brands. As of May 31, 2023, we operated two reportable segments: Home & Outdoor and Beauty & Wellness. During the fourth quarter of fiscal 2023, we made changes to the structure of our organization in connection with our global restructuring plan (as further described below and in Note 7) that resulted in our previous Health & Wellness and Beauty operating segments being combined into a single reportable segment, which is referred to herein as “Beauty & Wellness.” In connection with these organizational structure changes, corresponding changes were made to how our business is managed, how results are reported internally and how our Chief Executive Officer (“CEO”), our chief operating decision maker, assesses performance and allocates resources. We believe that these changes better align internal resources and external go to market activities in order to create a more efficient and effective organizational structure. There were no changes to the products or brands included within our Home & Outdoor reportable segment as part of these organizational changes nor to the way in which our CEO assesses performance and allocates resources for the Home & Outdoor segment. As a result of these changes, our disclosures reflect two reportable segments, Home & Outdoor and Beauty & Wellness. Comparative prior period segment information in this report has been recast to conform to this change in our reportable segments. Our external reportable segments will continue to align with our internal reporting to enable users of the financial statements to better understand our performance, better assess our future net cash flows, and make more informed judgments about the Company as a whole.

Our Home & Outdoor segment provides a broad range of outstanding world-class brands that help consumers enjoy an outdoor lifestyle and make everyday living better. Our innovative products for home activities include food preparation, cooking, cleaning, organization, and beverage service. Our outdoor performance range includes hydration products, backpacks, and travel gear to ease your journey and inspire your next adventure. The Beauty & Wellness segment provides consumers with a broad range of
7
outstanding world-class brands for beauty and wellness. In Beauty, we deliver innovation through products such as hair styling appliances, grooming tools, and liquid-, solid-, and powder-based personal care products that help make everyone look and feel more beautiful. On the Wellness side, we are there when you need us most with highly regarded humidifiers, thermometers, water and air purifiers, heaters, and fans.

Our business is seasonal due to different calendar events, holidays and seasonal weather patterns. Our fiscal reporting period ends on the last day in February. Historically, our highest sales volume and operating income occur in our third fiscal quarter ending November 30th. We purchase our products from unaffiliated manufacturers, most of which are located in China, Mexico, Vietnam and the U.S.

During the second quarter of fiscal 2023, we focused on developing a global restructuring plan intended to expand operating margins through initiatives designed to improve efficiency and reduce costs (referred to as “Project Pegasus”). See Note 7 for additional information.

On April 22, 2022, we completed the acquisition of Recipe Products Ltd., a producer of innovative prestige hair care products for all types of curly and wavy hair under the Curlsmith brand (“Curlsmith”). The total purchase consideration was $147.9 million in cash, net of a final net working capital adjustment and cash acquired. The Curlsmith brand and products were added to the Beauty & Wellness segment. See Note 3 for additional information.

During fiscal 2022 and fiscal 2023, we divested certain assets within our Beauty & Wellness segment's mass channel personal care business, which included liquid, powder and aerosol products under brands such as Pert, Brut, Sure and Infusium (“Personal Care”). On June 7, 2021, we completed the sale of our North America Personal Care business to HRB Brands LLC, for $44.7 million in cash and recognized a gain on the sale in SG&A totaling $0.5 million. On March 25, 2022, we completed the sale of the Latin America and Caribbean Personal Care business to HRB Brands LLC, for $1.8 million in cash and recognized a gain on the sale in SG&A totaling $1.3 million.

Principles of Consolidation

The accompanying condensed consolidated financial statements are prepared in accordance with GAAP and include all of our subsidiaries. Our condensed consolidated financial statements are prepared in U.S. Dollars. All intercompany balances and transactions are eliminated in consolidation.

The preparation of consolidated financial statements in accordance with GAAP requires management to make estimates and assumptions that affect the amounts reported in our condensed consolidated financial statements and accompanying notes. Actual results may differ materially from those estimates.

Reclassifications

We have reclassified or combined certain amounts in the prior year's accompanying footnotes to conform with the current year's presentation.

Note 2 - New Accounting Pronouncements

Except for the changes discussed below, there have been no changes in the information provided in our Form 10-K.




8
Adopted

In September 2022, the FASB issued ASU 2022-04, Liabilities—Supplier Finance Programs (Subtopic 405-50): Disclosure of Supplier Finance Program Obligations, which requires a buyer in a supplier finance program to disclose qualitative and quantitative information about its program to allow a user of the financial statements to understand the program’s nature, activity during the period, changes from period to period, and potential magnitude. The amendments in ASU 2022-04 are effective for fiscal years, and interim periods within those fiscal years, beginning after December 15, 2022, with the exception for the amendment on rollforward information, which is effective for fiscal years beginning after December 15, 2023. The guidance should be applied retrospectively, except for the amendment on rollforward information, which should be applied prospectively. This ASU was effective for us in the first quarter of fiscal 2024, with the exception of the amendment on rollforward information, which will be effective for us in our Form 10-K for fiscal 2025. We adopted this ASU during the first quarter of fiscal 2024 and the adoption did not have an impact on our consolidated financial statement disclosures.

In October 2021, the FASB issued ASU 2021-08, Business Combinations (Topic 805): Accounting for Contract Assets and Contract Liabilities from Contracts with Customers, which requires contract assets and contract liabilities acquired in a business combination to be recognized and measured by the acquirer on the acquisition date in accordance with ASC 606, Revenue from Contracts with Customers. Prior to the issuance of this guidance, contract assets and contract liabilities were recognized by the acquirer at fair value on the acquisition date. The amendments in ASU 2021-08 are effective for fiscal years, and interim periods within those fiscal years, beginning after December 15, 2022, and should be applied prospectively to acquisitions occurring on or after the effective date. We adopted this ASU during the first quarter of fiscal 2024 and the adoption did not have an impact on our consolidated financial statements.

Note 3 - Acquisition of Curlsmith

On April 22, 2022, we completed the acquisition of Recipe Products Ltd., a producer of innovative prestige hair care products for all types of curly and wavy hair under the Curlsmith brand. Curlsmith's products are a category leader in the market for prestige haircare products for curly hair and include conditioners, shampoos and co-washes purposefully designed for the unique joys and challenges of all types of curls and textured hair. The Curlsmith brand and products were added to the Beauty & Wellness segment. The total purchase consideration was $147.9 million in cash, net of a final net working capital adjustment of $2.1 million and cash acquired. The acquisition was funded with cash on hand and borrowings under our existing revolving credit facility. We incurred pre-tax acquisition-related expenses of $2.7 million during the first quarter of fiscal 2023, which were recognized in SG&A within our condensed consolidated statement of income.

We accounted for the acquisition as a purchase of a business and recorded the excess of the purchase price over the estimated fair value of the assets acquired and liabilities assumed as goodwill. The goodwill recognized is attributable primarily to expected synergies including leveraging our Beauty & Wellness segment's existing marketing and sales structure, as well as our global sourcing, distribution, shared service, and international go-to-market capabilities. The goodwill is not expected to be deductible for income tax purposes. We have determined the appropriate fair values of the acquired intangible assets and completed our analysis of the economic lives of the assets acquired. We assigned $21.0 million to trade names and are amortizing over a 20 year expected life. We assigned $12.0 million to customer relationships and are amortizing over a 19.5 year expected life, based on historical attrition rates.

During fiscal 2023, we made adjustments to provisional asset and liability balances, which resulted in a corresponding net increase to goodwill of $0.1 million. We also finalized the net working capital
9
adjustment during fiscal 2023, which resulted in a $1.8 million reduction to the total purchase consideration and goodwill. During the first quarter of fiscal 2024, we made final adjustments to provisional liability balances, which resulted in a corresponding increase to goodwill of $0.3 million.

The following table presents the estimated fair values of assets acquired and liabilities assumed at the acquisition date:
 (in thousands)
Assets: 
Receivables$4,211 
Inventory7,890 
Prepaid expenses and other current assets119 
Property and equipment212 
Goodwill117,108 
Trade names - definite21,000 
Customer relationships - definite12,000 
Deferred tax assets, net360 
Total assets162,900 
Liabilities:
Accounts payable1,401 
Accrued expenses and other current liabilities2,813 
Income taxes payable2,572 
Deferred tax liabilities, net8,187 
Total liabilities14,973 
Net assets recorded$147,927 

Both the fair value and gross contractual amount of receivables acquired was $4.2 million, as an immaterial amount was expected to be uncollectible.

The impact of the acquisition of Curlsmith on our condensed consolidated statements of income for the first quarter of fiscal 2023 was as follows:

April 22, 2022 (acquisition date) through May 31, 2022
(in thousands, except earnings per share data)
Three Months Ended May 31, 2022 (1)
Sales revenue, net$3,246 
Net income439 
EPS:
Basic$0.02 
Diluted$0.02 

(1)Represents approximately six weeks of operating results from Curlsmith, acquired April 22, 2022. Net income and EPS amounts include allocations for corporate expenses, interest expense and income tax expense.

10
The following supplemental unaudited pro forma information presents our financial results as if the acquisition of Curlsmith had occurred on March 1, 2021. This supplemental pro forma information has been prepared for comparative purposes and does not necessarily indicate what may have occurred if the acquisition had been completed on March 1, 2021, and this information is not intended to be indicative of future results.
(in thousands, except earnings per share data)Three Months Ended May 31, 2022
Sales revenue, net$515,170 
Net income26,508 
EPS:
Basic$1.11 
Diluted$1.10 

These amounts have been calculated after applying our accounting policies and adjusting the results of Curlsmith to reflect the effect of definite-lived intangible assets recognized as part of the business combination on amortization expense as if the acquisition had occurred on March 1, 2021.

Note 4 - Accrued Expenses and Other Current Liabilities

A summary of accrued expenses and other current liabilities was as follows:
(in thousands)May 31, 2023February 28, 2023
Accrued compensation, benefits and payroll taxes$23,525 $17,380 
Accrued sales discounts and allowances52,473 63,881 
Accrued sales returns29,880 28,498 
Accrued advertising32,204 36,931 
Other54,967 54,028 
Total accrued expenses and other current liabilities$193,049 $200,718 

Note 5 - Share-Based Compensation Plans

As part of our compensation structure, we grant share-based compensation awards to certain employees and non-employee members of our Board of Directors during the fiscal year. These awards may be subject to attainment of certain service conditions, performance conditions and/or market conditions. During the first quarter of fiscal 2024, we granted 94,807 service condition awards (“Service Condition Awards”) with a weighted average grant date fair value of $110.85. Additionally, we granted 252,522 performance-based awards during the first quarter of fiscal 2024, of which 126,318 contained performance conditions (“Performance Condition Awards”) and 126,204 contained market conditions (“Market Condition Awards”), with weighted average grant date fair values of $110.85 and $80.50, respectively. Refer to our Form 10-K for further information on the Company's share-based compensation plans.

11
We recorded share-based compensation expense in SG&A as follows:
 Three Months Ended May 31,
(in thousands)20232022
Directors stock compensation$197 $173 
Service Condition Awards3,320 3,117 
Performance Condition Awards2,023 10,845 
Market Condition Awards3,147 1,910 
Employee stock purchase plan610 574 
Share-based compensation expense9,297 16,619 
Less income tax benefits(641)(1,084)
Share-based compensation expense, net of income tax benefits$8,656 $15,535 

Unrecognized Share-Based Compensation Expense

As of May 31, 2023, our total unrecognized share-based compensation for all awards was $41.4 million, which will be recognized over a weighted average amortization period of 2.1 years. The total unrecognized share-based compensation reflects an estimate of target achievement for Performance Condition Awards granted during the first quarter of fiscal 2024, and an estimate of zero percent of target achievement for Performance Condition Awards granted in fiscal 2023 and fiscal 2022.

Note 6 - Repurchases of Common Stock

In August 2021, our Board of Directors authorized the repurchase of up to $500 million of our outstanding common stock. The authorization became effective August 25, 2021, for a period of three years, and replaced our former repurchase authorization. As of May 31, 2023, our repurchase authorization allowed for the purchase of $399.2 million of common stock.

Our current equity-based compensation plans include provisions that allow for the “net exercise” of share-settled awards by all plan participants. In a net exercise, any required payroll taxes, federal withholding taxes and exercise price of the shares due from the option or other share-based award holders are settled by having the holder tender back to us a number of shares at fair value equal to the amounts due. Net exercises are treated as purchases and retirements of shares.

The following table summarizes our share repurchase activity for the periods shown:
 Three Months Ended May 31,
(in thousands, except share and per share data)20232022
Common stock repurchased on the open market: 
Number of shares— — 
Aggregate value of shares$— $— 
Average price per share$— $— 
Common stock received in connection with share-based compensation:
Number of shares44,632 89,458 
Aggregate value of shares$4,446 $18,224 
Average price per share$99.61 $203.71 

Note 7 - Restructuring Plan

During the second quarter of fiscal 2023, we focused on developing Project Pegasus, a global restructuring plan intended to expand operating margins through initiatives designed to improve efficiency
12
and reduce costs. Project Pegasus includes initiatives to further optimize our brand portfolio, streamline and simplify the organization, accelerate cost of goods savings projects, enhance the efficiency of our supply chain network, optimize our indirect spending, and improve our cash flow and working capital, as well as other activities. We anticipate these initiatives will create operating efficiencies, as well as provide a platform to fund future growth investments.

During the fourth quarter of fiscal 2023, we made changes to the structure of our organization in connection with Project Pegasus that resulted in our previous Health & Wellness and Beauty operating segments being combined into a single reportable segment, which is referred to herein as “Beauty & Wellness.” In connection with these organizational structure changes, corresponding changes were made to how our business is managed, how results are reported internally and how our CEO, our chief operating decision maker, assesses performance and allocates resources. We believe that these changes better align internal resources and external go to market activities in order to create a more efficient and effective organizational structure. There were no changes to the products or brands included within our Home & Outdoor reportable segment as part of these organizational changes.

As part of our initiative focused on streamlining and simplifying the organization, we made further changes to the structure of our organization, during the fourth quarter of fiscal 2023, which include the creation of a North America Regional Market Organization (“RMO”) responsible for sales and go to market strategies for all categories and channels in the U.S. and Canada, and further centralization of certain functions under shared services, particularly in operations and finance to better support our business segments and RMOs. This new structure, inclusive of the organizational structure changes described above resulting in the reportable segment change, will reduce the size of our global workforce by approximately 10%. The majority of the role reductions were completed by March 1, 2023, and nearly all of the remaining role reductions are expected to be completed before the end of fiscal year 2024. We believe that these changes better focus business segment resources on brand development, consumer-centric innovation and marketing, the RMOs on sales and go to market strategies, and shared services on their respective areas of expertise while also creating a more efficient and effective organizational structure.

We continue to have the following expectations regarding Project Pegasus:
•Targeted annualized pre-tax operating profit improvements of approximately $75 million to $85 million, which we expect to substantially begin in fiscal 2024 and be substantially achieved by the end of fiscal 2026.
•Estimated cadence of the recognition of the savings will be approximately 25% in fiscal 2024, approximately 50% in fiscal 2025 and approximately 25% in fiscal 2026.
•Total profit improvements to be realized approximately 60% through reduced cost of goods sold and 40% through lower SG&A.
•Total one-time pre-tax restructuring charges of approximately $85 million to $95 million over the duration of the plan, which are expected to be substantially completed by the end of fiscal 2024 and will primarily be comprised of severance and employee related costs, professional fees, contract termination costs, and other exit and disposal costs.
•All of our operating segments and shared services will be impacted by the plan.

During the three month period ended May 31, 2023, we incurred $7.4 million of pre-tax restructuring costs in connection with Project Pegasus, which were recorded as “Restructuring charges” in the condensed consolidated statement of income.
13
The following table summarizes restructuring charges recorded as a result of Project Pegasus for the periods presented:
 Three Months Ended May 31, 2023Total
Incurred Since Inception
(in thousands)Home &
Outdoor		Beauty & WellnessTotal
Severance and employee related costs$484 $408 $892 $10,345 
Professional fees2,269 3,357 5,626 22,375 
Contract termination— 688 688 1,223 
Other37 112 149 774 
Total restructuring charges$2,790 $4,565 $7,355 $34,717 

The table below presents a rollforward of our accruals related to Project Pegasus, which are included in accounts payable and accrued expenses and other current liabilities:
(in thousands)Balance at February 28, 2023ChargesPaymentsBalance at May 31, 2023
Severance and employee related costs$3,173 $892 $(2,316)$1,749 
Professional fees3,201 5,626 (6,026)2,801 
Contract termination160 688 (848)— 
Other34 149 (183)— 
Total$6,568 $7,355 $(9,373)$4,550 

Note 8 - Commitments and Contingencies

Legal Matters

We are involved in various legal claims and proceedings in the normal course of operations. We believe the outcome of these matters will not have a material adverse effect on our consolidated financial position, results of operations or liquidity, except as described below.

On December 23, 2021, Brita LP filed a complaint against Kaz USA, Inc. and Helen of Troy Limited in the United States District Court for the Western District of Texas (the “Patent Litigation”), alleging patent infringement by the Company relating to its PUR gravity-fed water filtration systems. In the Patent Litigation, Brita LP seeks monetary damages and injunctive relief relating to the alleged infringement. Brita LP simultaneously filed a complaint with the United States International Trade Commission (“ITC”) against Kaz USA, Inc., Helen of Troy Limited and five other unrelated companies that sell water filtration systems (the “ITC Action”). The complaint in the ITC Action also alleges patent infringement by the Company with respect to a limited set of PUR gravity-fed water filtration systems. In the ITC Action, Brita LP requested the ITC to initiate an unfair import investigation relating to such filtration systems. This action seeks injunctive relief to prevent entry of certain accused PUR products (and certain other products) into the U.S. and cessation of marketing and sales of existing inventory that is already in the U.S. On January 25, 2022, the ITC instituted the investigation requested by the ITC Action. Discovery closed in the ITC Action in May 2022, and approximately half of the originally identified PUR gravity-fed water filters were removed from the case and are no longer included in the ITC Action. In August 2022, the parties participated in the evidentiary hearing, with additional supplemental hearings in October 2022. On February 28, 2023, the ITC issued an Initial Determination in the ITC Action, tentatively ruling against Kaz USA, Inc. and the other unrelated respondents. The ITC has a guaranteed review process, and thus all respondents, including Kaz USA, Inc., filed a petition with the ITC for a full review of the Initial Determination prior to the ITC making any final decision in this matter. On June 28, 2023, the ITC issued a Determination to review in part the Initial Determination and requested written submissions from the parties on certain issues under review. We intend to file the requested written submissions and then will await a final decision, which is now expected by September 19, 2023. The Patent Litigation has been stayed pending resolution of the ITC Action. While we intend to continue to vigorously pursue our claims
14
and defenses in these proceedings, we have also implemented mitigation plans to help minimize the expected potential impact to the Company, its customers and consumers of a negative ITC decision. These mitigation plans include the introduction of an alternative replacement water filter that could be distributed to customers promptly following a potentially adverse ITC decision at the end of June. We cannot predict the outcome of these proceedings, the amount or range of any potential loss, when the proceedings will be resolved, or customer acceptance of any replacement water filter. Litigation is inherently unpredictable, and the resolution or disposition of these proceedings could, if adversely determined, have a material and adverse impact on our financial position and results of operations.

Regulatory Matters

Our operations are subject to national, state, local, and provincial jurisdictions’ environmental, health and safety laws and regulations and industry-specific product certifications. Many of the products we sell are subject to product safety laws and regulations in various jurisdictions. These laws and regulations specify the maximum allowable levels of certain materials that may be contained in our products, provide statutory prohibitions against misbranded and adulterated products, establish ingredients and manufacturing procedures for certain products, specify product safety testing requirements, and set product identification, labeling and claim requirements. Some product lines within our Beauty & Wellness segment are subject to product identification, labeling and claim requirements, which are monitored and enforced by regulatory agencies, such as the U.S. Environmental Protection Agency (the “EPA”), U.S. Customs and Border Protection, the U.S. Food and Drug Administration, and the U.S. Consumer Product Safety Commission.

During fiscal 2022, we were in discussions with the EPA regarding the compliance of packaging claims on certain of our products in the air and water filtration categories and a limited subset of humidifier products within the Beauty & Wellness segment that are sold in the U.S. The EPA did not raise any product quality, safety or performance issues. As a result of these packaging compliance discussions, we voluntarily implemented a temporary stop shipment action on the impacted products as we worked with the EPA towards an expedient resolution. We resumed normalized levels of shipping of the affected inventory during fiscal 2022 and we completed the repackaging of our existing inventory of impacted products during fiscal 2023. Additionally, as a result of continuing dialogue with the EPA, we executed further repackaging and relabeling plans on certain additional humidifier products and certain additional air filtration products, which were also completed during fiscal 2023. Although we are not aware of any fines or penalties related to this matter imposed against us by the EPA at this time, there can be no assurances that such fines or penalties will not be imposed in the future.

We recorded charges to cost of goods sold to write-off obsolete packaging for the affected products in our inventory on-hand and in-transit. We have also incurred additional compliance costs comprised of obsolete packaging, storage and other charges from vendors, which were recognized in cost of goods sold and incremental warehouse storage costs and legal fees, which were recognized in SG&A. We refer to these charges as “EPA compliance costs.” The following table provides a summary of EPA compliance costs incurred during the periods presented:

Three Months Ended May 31,
(in thousands)20232022
Cost of goods sold$— $9,455 
1
SG&A— 2,189 
Total EPA compliance costs$— $11,644 
(1)Includes a $4.4 million charge to write-off the obsolete packaging for the affected additional humidifier products and affected additional air filtration products in our inventory on-hand and in-transit as of the end of the first quarter of fiscal 2023.

15
In addition, we incurred and capitalized into inventory costs to repackage a portion of our existing inventory of the affected products beginning in the second quarter of fiscal 2022 through completion of the repackaging in the third quarter of fiscal 2023. For additional information refer to Part I, Item 2., “Management’s Discussion and Analysis of Financial Condition and Results of Operations,” including “EPA Compliance Costs”.

Weather-Related Incident

On March 30, 2022, a third-party facility that we utilize for inventory storage incurred severe damage from a weather-related incident. The inventory that was stored at this facility primarily related to our Beauty & Wellness segment. While the inventory was insured, some seasonal inventory and inventory designated for specific customer promotions was not accessible and subsequently determined to be damaged, and as a result, unfavorably impacted our net sales revenue during the first quarter of fiscal 2023. As a result of the damages to the inventory stored at the facility, we recorded a charge to write-off the damaged inventory totaling $34.4 million during the first quarter of fiscal 2023. These charges were fully offset by probable insurance recoveries of $34.4 million also recorded during the first quarter of fiscal 2023, which represented anticipated insurance proceeds, not to exceed the amount of the associated losses, for which receipt was deemed probable. The charges for the damaged inventory and the expected insurance recoveries are included in cost of goods sold in our condensed consolidated statement of income for the three months ended May 31, 2022. During the third and fourth quarters of fiscal 2023, we received proceeds totaling $46.0 million from our insurance carriers related to this incident, which were included in cash flows from operating activities in our condensed consolidated statements of cash flows. As a result, during the third quarter of fiscal 2023, the Company recorded a gain of $9.7 million, net of costs incurred to dispose of the inventory, as a reduction of SG&A expense in our condensed consolidated statement of income.

Note 9 - Long-Term Debt
A summary of our long-term debt follows:
(in thousands)May 31, 2023February 28, 2023
Credit Agreement (1):
Revolving loans594,000 690,000 
Term loans245,312 246,875 
Total borrowings under Credit Agreement839,312 936,875 
Unamortized prepaid financing fees(2,155)(2,463)
Total long-term debt837,157 934,412 
Less: current maturities of long-term debt(6,235)(6,064)
Long-term debt, excluding current maturities$830,922 $928,348 
(1)The weighted average interest rates on borrowings outstanding under the Credit Agreement (defined below) as of May 31, 2023 and February 28, 2023 were 6.8% and 6.6%, respectively.

Capitalized Interest

During the three month periods ended May 31, 2023 and 2022, we incurred interest costs totaling $14.9 million and $5.1 million, respectively, of which we capitalized $0.9 million and $0.7 million, respectively, as part of property and equipment in connection with the construction of a new distribution facility.

16
Credit Agreement

We have a credit agreement (the “Credit Agreement”) with Bank of America, N.A., as administrative agent, and other lenders that provides for an unsecured total revolving commitment of $1.25 billion and a $300 million accordion, which can be used for term loan commitments. In June 2022, we exercised $250 million of the $300 million accordion under the Credit Agreement and borrowed $250 million as term loans. The proceeds from the term loans were used to repay revolving loans under the Credit Agreement. The term loans are payable at the end of each fiscal quarter in equal installments of 0.625% of the term loans made, which began in the third quarter of fiscal 2023, with the remaining balance due at the maturity date. The maturity date of the term loans and the revolving loans under the Credit Agreement is March 13, 2025. Borrowings under the Credit Agreement bear floating interest at either the Base Rate or Term SOFR (as defined in the Credit Agreement), plus a margin based on the Net Leverage Ratio (as defined in the Credit Agreement) of 0% to 1.0% and 1.0% to 2.0% for Base Rate and Term SOFR borrowings, respectively, plus a credit spread of 0.10% for Term SOFR borrowings.

The floating interest rates on our borrowings under the Credit Agreement are hedged with interest rate swaps to effectively fix interest rates on $625 million and $425 million of the outstanding principal balance under the revolving loans as of May 31, 2023 and February 28, 2023, respectively. See Notes 10, 11, and 12 for additional information regarding our interest rate swaps.

As of May 31, 2023, the balance of outstanding letters of credit was $18.2 million and the amount available for revolving loans under the Credit Agreement was $637.8 million. Covenants in the Credit Agreement limit the amount of total indebtedness we can incur. As a result of our exercise of a qualified acquisition notice under the Credit Agreement, as of May 31, 2023, these covenants effectively limited our ability to incur more than $343.0 million of additional debt from all sources, including the Credit Agreement.

Debt Covenants

As of May 31, 2023, we were in compliance with all covenants as defined under the terms of the Credit Agreement.

Note 10 - Fair Value 

Fair value is defined as the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. Valuation techniques under the accounting guidance related to fair value measurements are based on observable and unobservable inputs. These inputs are classified into the following hierarchy:

Level 1:Quoted prices for identical assets or liabilities in active markets;

Level 2:Observable inputs other than quoted prices that are directly or indirectly observable for the asset or liability, including quoted prices for similar assets or liabilities in active markets; quoted prices for similar or identical assets or liabilities in markets that are not active; and model-derived valuations whose inputs are observable or whose significant value drivers are observable; and

Level 3:Unobservable inputs that reflect the reporting entity’s own assumptions.
17
Our financial assets and liabilities are classified as Level 2 because their valuation is dependent on observable inputs and other quoted prices for similar assets or liabilities, or model-derived valuations whose significant value drivers are observable. The following table presents the carrying amount and fair value of our financial assets and liabilities measured and recorded at fair value on a recurring basis and classified as Level 2:
 Carrying Amount and Fair Value
(in thousands)May 31, 2023February 28, 2023
Assets: 
Cash equivalents (money market accounts)$10,745 $381 
Interest rate swaps2,527 5,746 
Foreign currency derivatives1,081 1,423 
Total assets$14,353 $7,550 
  
Liabilities: 
Interest rate swaps$822 $— 
Foreign currency derivatives1,177 711 
Total liabilities$1,999 $711 

The carrying amounts of cash, accounts payable, accrued expenses and other current liabilities and income taxes payable approximate fair value because of the short maturity of these items. The carrying amounts of receivables approximate fair value due to the effect of the related allowance for credit losses. The carrying amount of our floating rate long-term debt approximates its fair value.

We use derivatives to manage our exposure to changes in foreign currency exchange rates, which include foreign currency forward contracts and cross-currency debt swaps. In addition, we use interest rate swaps to manage our exposure to changes in interest rates. All of our derivative assets and liabilities are recorded at fair value. See Notes 11 and 12 for more information on our derivatives.

Note 11 - Financial Instruments and Risk Management

Foreign Currency Risk

The U.S. Dollar is the functional currency for the Company and all of its subsidiaries and is also the reporting currency for the Company. By operating internationally, we are subject to foreign currency risk from transactions denominated in currencies other than the U.S. Dollar (“foreign currencies”). Such transactions include sales and operating expenses. As a result of such transactions, portions of our cash, trade accounts receivable and trade accounts payable are denominated in foreign currencies. Approximately 15% and 13% of our net sales revenue was denominated in foreign currencies during the three month periods ended May 31, 2023 and 2022, respectively. These sales were primarily denominated in Euros, British Pounds and Canadian Dollars. We make most of our inventory purchases from manufacturers in Asia and primarily use the U.S. Dollar for such purchases.

During the three month periods ended May 31, 2023 and 2022, we recorded foreign currency exchange rate net gains of $0.4 million and $0.2 million, respectively, in SG&A. We mitigate certain foreign currency exchange rate risk by using forward contracts and cross-currency debt swaps to protect against the foreign currency exchange rate risk inherent in our transactions denominated in foreign currencies. We do not enter into any derivatives or similar instruments for trading or other speculative purposes. Certain of our forward contracts are designated as cash flow hedges (“foreign currency contracts”) and are recorded on the balance sheet at fair value with changes in fair value recorded in Other Comprehensive Income (Loss) (“OCI”) until the hedge transaction is settled, at which point amounts are reclassified from Accumulated Other Comprehensive Income (Loss) (“AOCI”) to our condensed
18
consolidated statements of income. Foreign currency derivatives for which we have not elected hedge accounting consist of our forward contracts and cross-currency debt swaps, and any changes in the fair value of these derivatives are recorded in our condensed consolidated statements of income. These undesignated derivatives are used to hedge monetary net asset and liability positions. Cash flows from our foreign currency derivatives are classified as cash flows from operating activities in our condensed consolidated statements of cash flows, which is consistent with the classification of the cash flows from the underlying hedged item. We evaluate our derivatives designated as cash flow hedges each quarter to assess hedge effectiveness.

Interest Rate Risk

Interest on our outstanding debt as of May 31, 2023 is based on floating interest rates. If short-term interest rates increase, we will incur higher interest expense on any future outstanding balances of floating rate debt. Floating interest rates are hedged with interest rate swaps to effectively fix interest rates on a portion of our outstanding principal balance under the Credit Agreement, which totaled $839.3 million and $936.9 million as of May 31, 2023 and February 28, 2023, respectively. As of May 31, 2023 and February 28, 2023, $625.0 million and $425.0 million of the outstanding principal balance under the Credit Agreement, respectively, was hedged with interest rate swaps to fix the interest rate we pay. Our interest rate swaps are designated as cash flow hedges and are recorded on the balance sheet at fair value with changes in fair value recorded in OCI until the hedge transaction is settled, at which point amounts are reclassified from AOCI to our condensed consolidated statements of income. Cash flows from our interest rate swaps are classified as cash flows from operating activities in our condensed consolidated statements of cash flows, which is consistent with the classification of the cash flows from the underlying hedged item. We evaluate our derivatives designated as cash flow hedges each quarter to assess hedge effectiveness.

The following tables summarize the fair values of our derivative instruments as of the end of the periods presented:
(in thousands)May 31, 2023

Derivatives designated as hedging instruments		Hedge
Type		Final
Settlement Date		Notional AmountPrepaid
Expenses
and Other
Current Assets		Other AssetsAccrued
Expenses
and Other
Current Liabilities		Other
Liabilities, Non- Current
Forward contracts - sell EuroCash flow2/2024€27,350 $58 $— $27 $— 
Forward contracts - sell Canadian DollarsCash flow2/2024$25,500 730 — — — 
Forward contracts - sell PoundsCash flow2/2024£23,525 — — 1,150 — 
Forward contracts - sell Norwegian KronerCash flow10/2023kr30,000 288 — — — 
Interest rate swapsCash flow2/2026$625,000 2,527 — — 822 
Subtotal   3,603 — 1,177 822 
Derivatives not designated under hedge accounting       
Forward contracts - buy Euro(1)6/2023€160 5 — — — 
Subtotal   5 — — — 
Total fair value$3,608 $— $1,177 $822 

19
(in thousands)February 28, 2023

Derivatives designated as hedging instruments		Hedge TypeFinal
Settlement Date		Notional AmountPrepaid
Expenses
and Other
Current Assets		Other AssetsAccrued
Expenses
and Other
Current Liabilities		Other
Liabilities Non- Current
Forward contracts - sell EuroCash flow2/2024€29,310 $257 $— $— $— 
Forward contracts - sell Canadian DollarsCash flow2/2024$30,000 962 11 — — 
Forward contracts - sell PoundsCash flow1/2024£19,400 — — 711 — 
Forward contracts - sell Norwegian KronerCash flow2/2024kr40,000 185 — — — 
Interest rate swapsCash flow2/2026$425,000 3,941 1,805 — — 
Subtotal   5,345 1,816 711 — 
Derivatives not designated under hedge accounting       
Forward contracts - buy Euro(1)3/2023€500 6 — — — 
Forward contracts - buy Pounds(1)3/2023£400 2 — — — 
Subtotal   8 — — — 
Total fair value   $5,353 $1,816 $711 $— 

(1)These forward contracts, for which we have not elected hedge accounting, hedge monetary net asset and liability positions for the notional amounts reported, creating an economic hedge against currency movements.

The pre-tax effects of derivative instruments designated as cash flow hedges were as follows for the periods presented:
 Three Months Ended May 31,
 Gain (Loss)
Recognized in AOCI		Gain (Loss) Reclassified
from AOCI into Income
(in thousands)20232022Location20232022
Foreign currency contracts - cash flow hedges$(467)$2,319 Sales revenue, net$338 $1,196 
Interest rate swaps - cash flow hedges(2,634)2,206 Interest expense1,407 (680)
Total$(3,101)$4,525  $1,745 $516 

The pre-tax effects of derivative instruments not designated under hedge accounting were as follows for the periods presented:

 Gain (Loss) 
Recognized in Income
Three Months Ended May 31,
(in thousands)Location20232022
Forward contractsSG&A$(24)$— 
Cross-currency debt swaps - principalSG&A— 875 
Total $(24)$875 

We expect a net gain of $2.4 million associated with foreign currency contracts and interest rate swaps currently recorded in AOCI to be reclassified into income over the next twelve months. The amount ultimately realized, however, will differ as exchange rates and interest rates change and the underlying contracts settle. See Notes 10 and 12 to these condensed consolidated financial statements for more information.

20
Counterparty Credit Risk

Financial instruments, including foreign currency contracts, forward contracts, cross-currency debt swaps and interest rate swaps, expose us to counterparty credit risk for non-performance. We manage our exposure to counterparty credit risk by only dealing with counterparties who are substantial international financial institutions with significant experience using such derivative instruments. We believe that the risk of incurring credit losses is remote.

Note 12 - Accumulated Other Comprehensive Income (Loss)

The changes in AOCI by component and related tax effects for the periods presented were as follows:
(in thousands)Interest
Rate Swaps		Foreign
Currency
Contracts		Total
Balance at February 28, 2022$(2,126)$2,328 $202 
Other comprehensive income before reclassification2,206 2,319 4,525 
Amounts reclassified out of AOCI680 (1,196)(516)
Tax effects(680)(170)(850)
Other comprehensive income2,206 953 3,159 
Balance at May 31, 2022$80 $3,281 $3,361 
Balance at February 28, 2023$4,394 $553 $4,947 
Other comprehensive loss before reclassification(2,634)(467)(3,101)
Amounts reclassified out of AOCI(1,407)(338)(1,745)
Tax effects949 182 1,131 
Other comprehensive loss(3,092)(623)(3,715)
Balance at May 31, 2023$1,302 $(70)$1,232 
See Notes 9, 10 and 11 to these condensed consolidated financial statements for additional information regarding our cash flow hedges.

Note 13 - Segment Information
We currently operate two reportable segments consisting of Home & Outdoor and Beauty & Wellness. During the fourth quarter of fiscal 2023, we made changes to the structure of our organization in connection with our global restructuring plan that resulted in our previous Health & Wellness and Beauty operating segments being combined into a single reportable segment, which is referred to herein as “Beauty & Wellness.” Comparative prior period segment information in this report has been recast to conform to this change in our reportable segments. See Note 1 to these condensed consolidated financial statements for additional information.
The following tables summarize segment information for the periods presented:
Three Months Ended May 31, 2023
(in thousands)Home & OutdoorBeauty & WellnessTotal
Sales revenue, net$217,144 $257,528 $474,672 
Restructuring charges2,790 4,565 7,355 
Operating income22,116 18,525 40,641 
Capital and intangible asset expenditures10,960 917 11,877 
Depreciation and amortization4,402 6,313 10,715 
21
Three Months Ended May 31, 2022
(in thousands)Home & OutdoorBeauty & WellnessTotal
Sales revenue, net$234,263 $273,815 $508,078 
Restructuring charges— 2 2 
Operating income 29,793 4,146 33,939 
Capital and intangible asset expenditures72,731 3,471 76,202 
Depreciation and amortization4,495 6,003 10,498 

The following table presents net sales revenue by geographic region, in U.S. Dollars:
Three Months Ended May 31,
(in thousands)20232022
Domestic sales revenue, net (1)$359,559 75.7 %$396,746 78.1 %
International sales revenue, net115,113 24.3 %111,332 21.9 %
Total sales revenue, net$474,672 100.0 %$508,078 100.0 %
(1)Beginning in the fourth quarter of fiscal 2023, we included net sales revenue from the U.S. and Canada as domestic net sales revenue. Previously, we reported sales revenue from Canada within international net sales revenue. We have recast the prior period domestic and international net sales revenue presented to conform with this current presentation.

Note 14 - Income Taxes

We reorganized the Company in Bermuda in 1994 and many of our foreign subsidiaries are not directly or indirectly owned by a U.S. parent. As such, a large portion of our foreign income is not subject to U.S. taxation on a permanent basis under current law. Additionally, our intellectual property is largely owned by foreign subsidiaries, resulting in proportionally higher earnings in jurisdictions with lower statutory tax rates, which decreases our overall effective tax rate. The taxable income earned in each jurisdiction, whether U.S. or foreign, is determined by the subsidiary's operating results and transfer pricing and tax regulations in the related jurisdictions.

For interim periods, our income tax expense and resulting effective tax rate are based upon an estimated annual effective tax rate adjusted for the effects of items required to be treated as discrete to the period, including changes in tax laws, changes in estimated exposures for uncertain tax positions and other items.

For the three months ended May 31, 2023, income tax expense as a percentage of income before income tax was 15.5% compared to 17.0% for the same period last year. The year-over-year decrease in the effective tax rate is primarily due to a decrease in tax expense for discrete items, partially offset by shifts in the mix of income in our various tax jurisdictions.

Note 15 - Earnings Per Share

We compute basic earnings per share using the weighted average number of shares of common stock outstanding during the period. We compute diluted earnings per share using the weighted average number of shares of common stock outstanding plus the effect of dilutive securities. Dilutive securities at any given point in time may consist of outstanding options to purchase common stock and issued and contingently issuable unvested restricted stock units, performance stock units, restricted stock awards and performance restricted stock awards and other stock-based awards. Anti-dilutive securities are not included in the computation of diluted earnings per share under the treasury stock method. See Note 5 to these condensed consolidated financial statements for more information regarding stock-based awards.

22
The following table presents our weighted average basic and diluted shares outstanding for the periods shown:
 Three Months Ended May 31,
(in thousands)20232022
Weighted average shares outstanding, basic24,049 23,865 
Incremental shares from share-based compensation arrangements85 257 
Weighted average shares outstanding, diluted24,134 24,122 
Anti-dilutive securities156 29 

23
ITEM 2. MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS

This Management’s Discussion and Analysis of Financial Condition and Results of Operations (“MD&A”) should be read in conjunction with our condensed consolidated financial statements included under Part I, Item 1., “Financial Statements.” The various sections of this MD&A contain a number of forward-looking statements, all of which are based on our current expectations. Actual results may differ materially due to a number of factors, including those discussed in the section entitled “Information Regarding Forward-Looking Statements” following this MD&A, and in Part I, Item 3., “Quantitative and Qualitative Disclosures About Market Risk” in this report, as well as in Part I, Item IA., “Risk Factors” in the Company’s most recent annual report on Form 10-K for the fiscal year ended February 28, 2023 (“Form 10-K”) and its other filings with the Securities and Exchange Commission (the “SEC”). When used in this MD&A, unless otherwise indicated or the context suggests otherwise, references to “the Company”, “our Company”, “Helen of Troy”, “we”, “us”, or “our” refer to Helen of Troy Limited and its subsidiaries. Throughout this MD&A, we refer to our Leadership Brands, which are brands that have number-one and number-two positions in their respective categories and include OXO, Hydro Flask, Osprey, Vicks, Braun, Honeywell, PUR, Hot Tools and Drybar.

This MD&A, including the tables under the headings “Operating Income, Operating Margin, Adjusted Operating Income (non-GAAP), and Adjusted Operating Margin (non-GAAP) by Segment” and “Net Income, Diluted EPS, Adjusted Income (non-GAAP), and Adjusted Diluted EPS (non-GAAP),” reports operating income, operating margin, net income and diluted earnings per share (“EPS”) without the impact of acquisition-related expenses, a charge for uncollectible receivables due to the bankruptcy of Bed, Bath & Beyond (“Bed, Bath & Beyond bankruptcy”), EPA compliance costs, restructuring charges, amortization of intangible assets, and non-cash share-based compensation for the periods presented, as applicable. These measures may be considered non-GAAP financial measures as defined by SEC Regulation G, Rule 100. The tables reconcile these measures to their corresponding GAAP-based financial measures presented in our condensed consolidated statements of income. We believe that adjusted operating income, adjusted operating margin, adjusted income, and adjusted diluted EPS provide useful information to management and investors regarding financial and business trends relating to our financial condition and results of operations. We believe that these non-GAAP financial measures, in combination with our financial results calculated in accordance with GAAP, provide investors with additional perspective regarding the impact of such charges and benefits on applicable income, margin and earnings per share measures. We also believe that these non-GAAP measures facilitate a more direct comparison of our performance to our competitors. We further believe that including the excluded charges and benefits would not accurately reflect the underlying performance of our operations for the period in which the charges and benefits are incurred, even though such charges and benefits may be incurred and reflected in our GAAP financial results in the near future. The material limitation associated with the use of the non-GAAP financial measures is that the non-GAAP measures do not reflect the full economic impact of our activities. Our adjusted operating income, adjusted operating margin, adjusted income, and adjusted diluted EPS are not prepared in accordance with GAAP, are not an alternative to GAAP financial measures and may be calculated differently than non-GAAP financial measures disclosed by other companies. Accordingly, undue reliance should not be placed on non-GAAP financial measures. These non-GAAP financial measures are discussed further and reconciled to their applicable GAAP-based financial measures contained in this MD&A beginning on page 36.

There were no material changes to the key financial measures discussed in our Form 10-K.



24
Overview

We incorporated as Helen of Troy Corporation in Texas in 1968 and were reorganized as Helen of Troy Limited in Bermuda in 1994. We are a leading global consumer products company offering creative products and solutions for our customers through a diversified portfolio of brands. We have built leading market positions through new product innovation, product quality and competitive pricing. We currently operate two segments consisting of Home & Outdoor and Beauty & Wellness.

During the fourth quarter of fiscal 2023, we made changes to the structure of our organization in connection with our global restructuring plan (as further described below and in Note 7 to the accompanying condensed consolidated financial statements) that resulted in our previous Health & Wellness and Beauty operating segments being combined into a single reportable segment, which is referred to herein as “Beauty & Wellness.” In connection with these organizational structure changes, corresponding changes were made to how our business is managed, how results are reported internally and how our Chief Executive Officer (“CEO”), our chief operating decision maker, assesses performance and allocates resources. We believe that these changes better align internal resources and external go to market activities in order to create a more efficient and effective organizational structure. There were no changes to the products or brands included within our Home & Outdoor reportable segment as part of these organizational changes nor to the way in which our CEO assesses performance and allocates resources for the Home & Outdoor segment. As a result of these changes, our disclosures reflect two reportable segments, Home & Outdoor and Beauty & Wellness. Comparative prior period segment information in this report has been recast to conform to this change in our reportable segments. Our external reportable segments will continue to align with our internal reporting to enable users of the financial statements to better understand our performance, better assess our future net cash flows, and make more informed judgments about the Company as a whole.

Fiscal 2020 began Phase II of our transformation, which was designed to drive the next five years of progress. The long-term objectives of Phase II include improved organic sales growth, continued margin expansion, and strategic and effective capital deployment. Phase II includes continued investment in our Leadership Brands, with a focus on growing them through consumer-centric innovation, expanding them more aggressively outside the United States of America (the “U.S.”), and adding new brands through acquisition. We are building further shared service capability and operating efficiency, as well as focusing on attracting, retaining, unifying and training the best people. Additionally, we are continuing to enhance and consolidate our environmental, social and governance efforts and accelerate programs related to diversity, equity, inclusion and belonging to support our Phase II transformation.

During the second quarter of fiscal 2023, we focused on developing a global restructuring plan intended to expand operating margins through initiatives designed to improve efficiency and reduce costs (referred to as “Project Pegasus”). Project Pegasus includes initiatives to further optimize our brand portfolio, streamline and simplify the organization, accelerate cost of goods savings projects, enhance the efficiency of our supply chain network, optimize our indirect spending, and improve our cash flow and working capital, as well as other activities. We anticipate these initiatives will create operating efficiencies, as well as provide a platform to fund future growth investments. During the three month period ended May 31, 2023, we incurred $7.4 million of pre-tax restructuring costs in connection with Project Pegasus, which were recorded as “Restructuring charges” in the condensed consolidated statement of income. See further discussion below within “Significant Trends Impacting the Business” under “Project Pegasus” and Note 7 to the accompanying condensed consolidated financial statements.

On April 22, 2022, we completed the acquisition of Recipe Products Ltd., a producer of innovative prestige hair care products for all types of curly and wavy hair under the Curlsmith brand (“Curlsmith”). The Curlsmith brand and products were added to the Beauty & Wellness segment. The total purchase consideration was $147.9 million in cash, net of a final net working capital adjustment and cash acquired.
25
On March 30, 2022, a third-party facility that we utilize for inventory storage incurred severe damage from a weather-related incident. The inventory that was stored at this facility primarily related to our Beauty & Wellness segment. While the inventory was insured, some seasonal inventory and inventory designated for specific customer promotions was not accessible and subsequently determined to be damaged, and as a result, unfavorably impacted our net sales revenue during the first quarter of fiscal 2023. As a result of the damages to the inventory stored at the facility, we recorded a charge to write-off the damaged inventory totaling $34.4 million during the first quarter of fiscal 2023. These charges were fully offset by probable insurance recoveries of $34.4 million also recorded during the first quarter of fiscal 2023, which represented anticipated insurance proceeds, not to exceed the amount of the associated losses, for which receipt was deemed probable. The charges for the damaged inventory and the expected insurance recoveries are included in cost of goods sold in our condensed consolidated statement of income for the three months ended May 31, 2022. During the third and fourth quarters of fiscal 2023, we received proceeds totaling $46.0 million from our insurance carriers related to this incident, which were included in cash flows from operating activities in our condensed consolidated statements of cash flows. As a result, during the third quarter of fiscal 2023, the Company recorded a gain of $9.7 million, net of costs incurred to dispose of the inventory, as a reduction of SG&A expense in our condensed consolidated statement of income.

Significant Trends Impacting the Business

Project Pegasus
During the second quarter of fiscal 2023, we focused on developing Project Pegasus, a global restructuring plan intended to expand operating margins through initiatives designed to improve efficiency and reduce costs. Project Pegasus includes initiatives to further optimize our brand portfolio, streamline and simplify the organization, accelerate cost of goods savings projects, enhance the efficiency of our supply chain network, optimize our indirect spending, and improve our cash flow and working capital, as well as other activities. We anticipate these initiatives will create operating efficiencies, as well as provide a platform to fund future growth investments.

As part of our initiative focused on streamlining and simplifying the organization, we made further changes to the structure of our organization, during the fourth quarter of fiscal 2023, which include the creation of a North America Regional Market Organization (“RMO”) responsible for sales and go to market strategies for all categories and channels in the U.S. and Canada, and further centralization of certain functions under shared services, particularly in operations and finance to better support our business segments and RMOs. This new structure, inclusive of the organizational structure changes described above resulting in the reportable segment change, will reduce the size of our global workforce by approximately 10%. The majority of the role reductions were completed by March 1, 2023, and nearly all of the remaining role reductions are expected to be completed before the end of fiscal year 2024. We believe that these changes better focus business segment resources on brand development, consumer-centric innovation and marketing, the RMOs on sales and go to market strategies, and shared services on their respective areas of expertise while also creating a more efficient and effective organizational structure.

We continue to have the following expectations regarding Project Pegasus:
•Targeted annualized pre-tax operating profit improvements of approximately $75 million to $85 million, which we expect to substantially begin in fiscal 2024 and be substantially achieved by the end of fiscal 2026.
•Estimated cadence of the recognition of the savings will be approximately 25% in fiscal 2024, approximately 50% in fiscal 2025 and approximately 25% in fiscal 2026.
•Total profit improvements to be realized approximately 60% through reduced cost of goods sold and 40% through lower SG&A.
26
•Total one-time pre-tax restructuring charges of approximately $85 million to $95 million over the duration of the plan, which are expected to be substantially completed by the end of fiscal 2024 and will primarily be comprised of severance and employee related costs, professional fees, contract termination costs, and other exit and disposal costs.
•All of our operating segments and shared services will be impacted by the plan.

In addition, we implemented plans to reduce inventory levels, increase inventory turns, and improve cash flow and working capital during the second quarter of fiscal 2023. Improvements related to these initiatives began in the second half of fiscal 2023, and we expect improvements to continue during fiscal 2024. Expectations regarding our Project Pegasus initiatives and our ability to realize targeted savings, including expectations concerning costs and savings, are based on management’s estimates available at the time and are subject to a number of assumptions that could materially impact our estimates.

During the three month period ended May 31, 2023, we incurred $7.4 million of pre-tax restructuring costs in connection with Project Pegasus, which were recorded as “Restructuring charges” in the condensed consolidated statement of income. We made total cash restructuring payments of $9.4 million during the three month period ended May 31, 2023 and had a remaining liability of $4.6 million as of May 31, 2023. See Note 7 to the accompanying condensed consolidated financial statements for additional information.

Water Filtration Patent Litigation
On December 23, 2021, Brita LP filed a complaint against Kaz USA, Inc. and Helen of Troy Limited in the United States District Court for the Western District of Texas (the “Patent Litigation”), alleging patent infringement by the Company relating to its PUR gravity-fed water filtration systems. Brita LP simultaneously filed a complaint with the United States International Trade Commission (“ITC”) against Kaz USA, Inc., Helen of Troy Limited and five other unrelated companies that sell water filtration systems (the “ITC Action”). The complaint in the ITC Action also alleges patent infringement by the Company with respect to a limited set of PUR gravity-fed water filtration systems. This action seeks injunctive relief to prevent entry of certain accused PUR products (and certain other products) into the U.S. and cessation of marketing and sales of existing inventory that is already in the U.S. On February 28, 2023, the ITC issued an Initial Determination in the ITC Action, tentatively ruling against Kaz USA, Inc. and the other unrelated respondents. The ITC has a guaranteed review process, and thus all respondents, including Kaz USA, Inc., filed a petition with the ITC for a full review of the Initial Determination prior to the ITC making any final decision in this matter. On June 28, 2023, the ITC issued a Determination to review in part the Initial Determination and requested written submissions from the parties on certain issues under review. We intend to file the requested written submissions and then will await a final decision, which is now expected by September 19, 2023. The Patent Litigation has been stayed pending resolution of the ITC Action. While we intend to continue to vigorously pursue our claims and defenses in these proceedings, we have also implemented mitigation plans to help minimize the expected potential impact to the Company, its customers and consumers of a negative ITC decision. These mitigation plans include the introduction of an alternative replacement water filter that could be distributed to customers promptly following a potentially adverse ITC decision at the end of June. We cannot predict the outcome of these proceedings, the amount or range of any potential loss, when the proceedings will be resolved, or customer acceptance of any replacement water filter. Litigation is inherently unpredictable, and the resolution or disposition of these proceedings could, if adversely determined, have a material and adverse impact on our financial position and results of operations. For additional information regarding the Patent Litigation and the ITC Action, see Note 8 to the accompanying condensed consolidated financial statements.

Impact of Macroeconomic Trends
The Federal Open Market Committee has been raising interest rates, and may continue to raise interest rates during the remainder of calendar year 2023. The Federal Open Market Committee increased the
27
benchmark interest rate by 450 basis points during fiscal year 2023. As a result, we incurred higher average interest rates during the first quarter of fiscal 2024 compared to the same period last year, and we expect this trend to continue during the remainder of fiscal 2024. While the actual timing and extent of future changes in interest rates remains unknown, higher average interest rates are expected to increase interest expense on our outstanding debt. The financial markets, the global economy and global supply chain may also be adversely affected by the current or anticipated impact of military conflict, including the current conflict between Russia and Ukraine, or other geopolitical events. High inflation and interest rates have also negatively impacted consumer disposable income, credit availability and spending, among others, which have adversely impacted our business, financial condition, cash flows and results of operations during the first quarter of fiscal 2024 and may continue to have an adverse impact during the remainder of fiscal year 2024. See further discussion below under “Consumer Spending and Changes in Shopping Preferences.” We expect continued uncertainty in our business and the global economy due to pressure from inflation, volatility in employment trends and consumer confidence, any of which may adversely impact our results.

Consumer Spending and Changes in Shopping Preferences
Our business depends upon discretionary consumer demand for most of our products and primarily operates within mature and highly developed consumer markets. The principal driver of our operating performance is the strength of the U.S. retail economy. Approximately 72% and 73% of our consolidated net sales revenue was from U.S. shipments during the three month periods ended May 31, 2023 and 2022, respectively.

Among other things, high levels of inflation and interest rates may negatively impact consumer disposable income, credit availability and spending. Consumer purchases of discretionary items, including the products that we offer, generally decline during recessionary periods or periods of economic uncertainty, when disposable income is reduced or when there is a reduction in consumer confidence. Dynamic changes in consumer spending and shopping patterns are also having an impact on retailer inventory levels. Our ability to sell to retailers is predicated on their ability to sell to the end consumer. During fiscal year 2023, we experienced an adverse impact on orders from retail customers as they aimed to rebalance their inventory levels due to lower consumer demand and shifts in consumer spending patterns. We experienced some improvement in replenishment orders from certain retail customers in certain product categories during the first quarter of fiscal 2024. If orders from our retail customers continue to be adversely impacted, our sales, results of operations and cash flows may continue to be adversely impacted. We expect continued uncertainty in our business and the global economy due to inflation and changes in consumer spending patterns. Accordingly, our liquidity and financial results could be impacted in ways that we are not able to predict today.

Our concentration of sales reflects the evolution of consumer shopping preferences to online or multichannel shopping experiences. Our net sales to retail customers fulfilling end-consumer online orders and online sales directly to consumers comprised approximately 26% of our total consolidated net sales revenue for the three month period ended May 31, 2023, and grew approximately 8% compared to the same period in the prior year.

For the three month period ended May 31, 2022, our net sales to retail customers fulfilling end-consumer online orders and online sales directly to consumers comprised approximately 22% of our total consolidated net sales revenue, and declined approximately 7%, compared to the same period in the prior year.

With the continued importance of online sales in the retail landscape, many brick and mortar retailers are aggressively looking for ways to improve their customer delivery capabilities to be able to meet customer expectations. As a result, it has become increasingly important for us to leverage our distribution capabilities in order to meet the changing demands of our customers, including increasing our online capabilities to support our direct-to-consumer sales channels and online channel sales by our retail
28
customers. In March 2023, we completed the construction of an additional distribution facility in Gallaway, Tennessee that became operational during the first quarter of fiscal 2024 and includes state-of-the-art automation. Additionally, we continue to invest in a centralized cloud-based e-commerce platform that we anticipate will enable us to leverage a common system and rapidly deploy new capabilities across all of our brands, as well as more easily integrate new brands. We anticipate this platform will enhance the customer experience by strengthening the digital presentation and product browsing capabilities and improving the checkout process, order delivery and post-order customer care.

EPA Compliance Costs
Some product lines within our Beauty & Wellness segment are subject to product identification, labeling and claim requirements, which are monitored and enforced by regulatory agencies, such as the U.S. Environmental Protection Agency (the “EPA”), U.S. Customs and Border Protection, the U.S. Food and Drug Administration, and the U.S. Consumer Product Safety Commission.

During fiscal 2022, we were in discussions with the EPA regarding the compliance of packaging claims on certain of our products in the air and water filtration categories and a limited subset of humidifier products within the Beauty & Wellness segment that are sold in the U.S. The EPA did not raise any product quality, safety or performance issues. As a result of these packaging compliance discussions, we voluntarily implemented a temporary stop shipment action on the impacted products as we worked with the EPA towards an expedient resolution. We resumed normalized levels of shipping of the affected inventory during fiscal 2022 and we completed the repackaging of our existing inventory of impacted products during fiscal 2023. Additionally, as a result of continuing dialogue with the EPA, we executed further repackaging and relabeling plans on certain additional humidifier products and certain additional air filtration products, which were also completed during fiscal 2023.

We recorded charges to cost of goods sold to write-off obsolete packaging for the affected products in our inventory on-hand and in-transit. We have also incurred additional compliance costs comprised of obsolete packaging, storage and other charges from vendors, which were recognized in cost of goods sold and incremental warehouse storage costs and legal fees, which were recognized in SG&A. We refer to these charges as “EPA compliance costs.” The following table provides a summary of EPA compliance costs incurred during the periods presented:
Three Months Ended May 31,
(in thousands)